Skip to main content
. 2023 Jul 28;26(3):397. doi: 10.3892/ol.2023.13983

Table III.

Analysis of treatment efficacy in patients according to PNI, ALI and AGR values.

Variable n CR PR SD PD ORR DCR
PNI
  Low 96 1 (1.0) 22 (22.9) 39 (40.6) 34 (35.4) 23 (24.0) 62 (64.6)
  High 99 2 (2.0) 43 (43.4) 35 (35.4) 19 (19.2) 45 (45.5) 80 (80.8)
  χ2 9.916 6.482
  P-value 0.002 0.011
ALI
  Low 98 0 (0.0) 31 (31.6) 37 (37.8) 30 (30.6) 31 (31.6) 68 (69.4)
  High 97 3 (3.1) 34 (35.1) 37 (38.1) 23 (23.7) 37 (38.1) 74 (76.3)
  χ2 0.910 1.173
  P-value 0.340 0.279
AGR
  Low 100 0 (0.0) 23 (23.0) 37 (37.0) 40 (40.0) 23 (23.0) 60 (60.0)
  High 95 3 (3.2) 42 (44.2) 37 (38.9) 13 (13.7) 45 (47.4) 82 (86.3)
  χ2 12.738 17.046
  P-value <0.001 <0.001

Data are presented as n (%). PNI, prognostic nutritional index; ALI, advanced lung cancer inflammation index; AGR, albumin-globulin ratio; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate.